# Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus

> **NCT03851055** · PHASE3 · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- Beta-thalassemia Major Complicated With Diabetes

## Interventions

- **DRUG:** Zinc

## Key facts

- **NCT ID:** NCT03851055
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-01
- **Primary completion:** 2018-07-10
- **Final completion:** 2018-08-28
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2019-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03851055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03851055, "Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03851055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*